Teppei Shimizu

A phase I trial of concurrent chemoradiotherapy with non-split administration of docetaxel and cisplatin for dry stage III non-small-cell lung cancer (JCOG9901DI)

H. Okamoto, T. Shimokawa, Koshiro Watanabe, 2012, Cancer Chemotherapy and Pharmacology.

Impact of Pharmacists’ audit on improving the quality of prescription of dabigatran etexilate methanesulfonate: a retrospective study

H. Echizen, Teppei Shimizu, R. Ogawa, 2017, Journal of Pharmaceutical Health Care and Sciences.

Potentiation of anticoagulant effect of warfarin caused by enantioselective metabolic inhibition by the uricosuric agent benzbromarone

T. Shimizu, H. Echizen, H. Tainaka, 1999, Clinical pharmacology and therapeutics.

Comparisons between in-vitro and in-vivo metabolism of (S)-warfarin: catalytic activities of cDNA-expressed CYP2C9, its Leu359 variant and their mixture versus unbound clearance in patients with the corresponding CYP2C9 genotypes.

T. Shimizu, H. Echizen, S. Nomoto, 1998, Pharmacogenetics.